fashion -WSS

fashion

author：hotspot 2025-08-19 14:58:12 - browse：7

A team of high-powered scientists and billionaire investors said Friday that they’re launching a biomedical institute in Cambridge’s Kendall Square with $500 million in private funding with the aim of shortening the path from research breakthroughs to life-saving medicines.

The institute, called Arena BioWorks, will put drug discovery and company creation under one roof, upending the traditional model where academic research and venture-backed drug development are separate.

Backed by deep-pocketed investors including Steve Pagliuca, the former co-chair of Bain Capital and Celtics co-owner, and high-tech mogul Michael Dell, Arena has already lured top scientists from academic labs with lucrative compensation packages, but so far has publicly named only a few.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： BMI, flaws aside, is found to be useful estimate of body fat in youth

focus

WSS

Covid misinformation case heads to Supreme Court

Some dementia cases could be undiagnosed liver disease

Woman returns to dialysis after doctors remove transplanted pig kidney

FDA's Pazdur wants cancer trials to range beyond China alone

Ultragenyx gene therapy for rare liver ailment succeeds in late

How to increase colonoscopy rates? Looks like an AI can help

knowledge

fashion

Wikipedia

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The Pandemic Treaty must support building strong health systems

Malaria cases in Florida and Texas: Here’s what you need to know

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Cancer drug shortages should be causing more outrage

With trial win, GSK could get blood cancer drug back on market

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Medicare proposal to cover medical devices draws a mixed reaction

Woodcock on FDA’s accelerated approval and her next chapter

hotspot

Even great ERs can’t make up for American health disparities

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Cybersecurity threat forces Lurie Children's to take systems offline

Cord blood banking comes at a high cost to babies

Innovation in antibiotics is ailing. 'Brain drain' may kill it

With trial win, GSK could get blood cancer drug back on market

focus

knowledge

focus

hotspot